Adverse Events and Oncotargeted Kinase Inhibitors / Najlacnejšie knihy
Adverse Events and Oncotargeted Kinase Inhibitors

Code: 14530603

Adverse Events and Oncotargeted Kinase Inhibitors

by Giuseppe Tridente

Adverse Events and Oncotargeted Kinase Inhibitorsgathers and evaluates data on adverse events associated with tyrosine kinase inhibitors (TKIs), a powerful anti-tumor drug class that has recently been introduced for human therapy. ... more

197.47

RRP: 207.23 €

You save 9.77 €

Availability:

50/50We think title might be available. Upon your order we will do our best to get it within 6 weeks.
We search the world

Availability alert

Add to wishlist

You might also like

Give this book as a present today
  1. Order book and choose Gift Order.
  2. We will send you book gift voucher at once. You can give it out to anyone.
  3. Book will be send to donee, nothing more to care about.

Book gift voucher sampleRead more

Availability alert

Availability alert


Your agreement - Submiting you agree to the Terms and Condtions.

We will watch availability for you

Enter your e-mail address and once book will be available,
we will send you a message. It's that simple.

More about Adverse Events and Oncotargeted Kinase Inhibitors

You get 491 loyalty points

Book synopsis

Adverse Events and Oncotargeted Kinase Inhibitorsgathers and evaluates data on adverse events associated with tyrosine kinase inhibitors (TKIs), a powerful anti-tumor drug class that has recently been introduced for human therapy. This book compiles a comprehensive safety profile of each TKI from experiences in official therapeutic indications, also exploring off-label exploratory investigations and postmarketing pharmaceutical surveillance databases. A brief history of each drug’s development and submission is provided, along with a more detailed analysis of the mechanism(s) of action involved in therapeutic activity or related to the insurgence of specific adverse events. Early chapters focus on general characteristics of TKIs, typology, and classification of adverse events, while the final chapters analyze TKIs as AE inducers and classes of AEs by system or organ involvement. This comprehensive resource compiles and critically reviews all of the relevant safety data for this class of drugs, with the goal of improving the understanding of pathogenesis and facilitating the prevention, monitoring, and management of these adverse events. Offers a unique and comprehensive publication on the adverse events associated with a new and fast-growing class of medicinesProvides a systematic analysis of adverse events aimed at better prevention through understanding and offering insights for the development of safer drugsUses practical guidelines to establish a leading reference on this class of drugs for educators, researchers, drug developers, clinicians, safety professionals, and more

Book details

Book category Books in English Medicine Other branches of medicine Pharmacology

197.47

Trending among others



Collection points Bratislava a 2642 dalších

Copyright ©2008-24 najlacnejsie-knihy.sk All rights reservedPrivacyCookies


Account: Log in
Všetky knihy sveta na jednom mieste. Navyše za skvelé ceny.

Shopping cart ( Empty )

For free shipping
shop for 59,99 € and more

You are here: